Holders over time
- HUM
- ELV
| Quarter | HUM | ELV |
|---|---|---|
| Q3 2020 | 30 holders, $18.0bn | 30 holders, $15.0bn |
| Q4 2020 | 30 holders, $17.6bn | 29 holders, $16.7bn |
| Q1 2021 | 26 holders, $17.2bn | 25 holders, $18.6bn |
| Q2 2021 | 28 holders, $18.1bn | 30 holders, $19.4bn |
| Q3 2021 | 33 holders, $16.8bn | 26 holders, $18.5bn |
| Q4 2021 | 29 holders, $20.3bn | 29 holders, $23.3bn |
| Q1 2022 | 32 holders, $17.7bn | 31 holders, $23.9bn |
| Q2 2022 | 29 holders, $18.1bn | 32 holders, $23.3bn |
| Q3 2022 | 32 holders, $17.7bn | 34 holders, $22.6bn |
| Q4 2022 | 31 holders, $17.2bn | 34 holders, $25.5bn |
| Q1 2023 | 31 holders, $16.7bn | 39 holders, $22.5bn |
| Q2 2023 | 28 holders, $14.2bn | 38 holders, $20.6bn |
| Q3 2023 | 35 holders, $16.5bn | 34 holders, $19.8bn |
| Q4 2023 | 34 holders, $13.3bn | 36 holders, $20.3bn |
| Q1 2024 | 37 holders, $9.8bn | 35 holders, $21.3bn |
| Q2 2024 | 34 holders, $11.3bn | 33 holders, $22.1bn |
| Q3 2024 | 28 holders, $8.4bn | 30 holders, $20.2bn |
| Q4 2024 | 19 holders, $7.3bn | 32 holders, $15.9bn |
| Q1 2025 | 26 holders, $7.3bn | 28 holders, $17.1bn |
| Q2 2025 | 24 holders, $6.7bn | 27 holders, $14.8bn |
| Q3 2025 | 17 holders, $6.5bn | 27 holders, $12.7bn |
| Q4 2025 | 14 holders, $6.5bn | 25 holders, $17.0bn |
| Q1 2026 | 14 holders, $3.8bn | 26 holders, $13.6bn |
| Q2 2026 | 25 holders, $10.6bn | 28 holders, $17.7bn |
Humana Inc
- Holders
- 34
- Reported value
- $11.3bn
- Buyers
- 19
- Sellers
- 18
Breadth +1 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 33
- Reported value
- $22.1bn
- Buyers
- 14
- Sellers
- 21
Breadth -7 among 94 comparable managers.
Who holds both, Q2 2024
Both (20)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Point72 Asset Management LP, T. Rowe Price Associates Inc, Two Sigma Investments LP, Voloridge Investment Management LLC, Wellington Management Group LLP
Only HUM (14)
Baupost Group LLC, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Farallon Capital Management LLC, Maverick Capital Ltd, PDT Partners LLC, Schonfeld Strategic Advisors LLC, Soros Fund Management LLC, Starboard Value LP, Steadfast Capital Management LP, Tudor Investment Corp, Two Sigma Advisers LP, Woodline Partners LP
Only ELV (13)
Baillie Gifford & Co, Brevan Howard Capital Management LP, Bridgewater Associates LP, D1 Capital Partners LP, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, First Eagle Investment Management LLC, Glenview Capital Management LLC, Jane Street Group LLC, Man Group PLC, Moore Capital Management LP, Ruane Cunniff & Goldfarb LP, Winton Group Ltd
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.